FIELD: pharmacology.
SUBSTANCE: invention concerns indazol derivatives of general formulae (I) 
or (II) 
, where radicals and groups are defined as shown in cl. 1 of invention claim, and their pharmaceutically acceptable salts. Also invention claims medicine, method of medicine obtainment and application of claimed compounds in treatment and/or prevention of fatty acid metabolism derangement and glucose assimilation disorders.
EFFECT: inhibition of hormone-sensitive lipases.
13 cl, 1 tbl, 103 ex
| Title | Year | Author | Number |
|---|---|---|---|
| N1/N2-LACTAM ACETYL-CoA-CARBOXYLASE INHIBITORS | 2011 |
|
RU2540337C2 |
| DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS KINASE 1β-ADRENERGIC RECEPTOR INHIBITORS | 2006 |
|
RU2415855C2 |
| INHIBITOR CONTAINING BICYCLIC DERIVATIVE, METHOD OF PREPARATION AND USE THEREOF | 2020 |
|
RU2820948C2 |
| NOVEL CLASS OF SELECTIVE AGONISTS OF SOMATOSTATIN RECEPTORS | 2014 |
|
RU2603962C2 |
| SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
| HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES | 2007 |
|
RU2479575C2 |
| NOVEL INDOLYSIN COMPOUNDS, METHOD FOR PRODUCING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2014 |
|
RU2693629C2 |
| COMPOUNDS AND THEIR USING FOR DECREASING HORMONE-SENSITIVE LIPASE ACTIVITY | 2002 |
|
RU2317981C2 |
| INDAZOLE COMPOUNDS AS FGFR KINASE INHIBITORS, PREPARATION AND USE THEREOF | 2015 |
|
RU2719428C2 |
